Siga Technologies to supply Morocco with Mpox therapy

American pharmaceutical company Siga Technologies announced on Tuesday that it would provide Morocco with its therapy for Mpox. The decision follows a request from the Moroccan Ministry of Health to address any possible outbreak of the disease, according to Reuters.

This marks Siga's first commercial sale of the therapy in Africa. The therapy is approved in the United States and Canada for the treatment of smallpox and is also authorized in Europe for smallpox, mpox, cowpox, and complications from vaccinia virus.

In August, the World Health Organization (WHO) declared a public health emergency of international concern after identifying a new variant of Mpox. Morocco has confirmed two cases of the disease this year, according to the WHO.